Dr Nijjer is an award-winning Consultant Cardiologist working at both the Hammersmith Hospital and Chelsea & Westminster Foundation NHS Trust. Dr Nijjer practices privately at the BUPA Cromwell Hospital, Bupa Health Centre at Canary Wharf, Clinic 66 Harley Street, Syon Clinic and the Hammersmith Hospital.
Dr Nijjer has expertise in Cardiology with subspeciality expertise in coronary intervention. He is a specialist in assessing patients with chest pain, breathlessness, palpitations, dizziness, faints, and ankle swelling.
Dr Nijjer is an expert in the management of coronary artery disease, including acute myocardial infarction (heart attacks). He performs coronary angiography, coronary angioplasty (stenting) and he also implants pacemakers. He is an expert in the use of coronary physiology and intravascular imaging to guide and optimise
Dr Nijjer also has expertise in anti-platelets medications and has been invited as a speaker at International conferences. He also has expertise in the use of CT coronary angiography to help diagnose patients efficiently and without the need for invasive procedure.
Trained across Premier London Hospitals
Dr. Nijjer has almost 20 years of experience in Healthcare and the NHS. He studied medicine at the University of Bristol, where he graduated with Honours with two undergraduate scholarships and numerous academic prizes. He was also awarded a First Class Honours degree in Pharmacology which was supported by the prestigious Wolfson Award from the Royal College of Physicians. He undertook his Junior Doctor and Specialty training at premier Hospitals in London, including the Hammersmith Hospital, Charing Cross Hospital, Harefield Hospital and the Royal Brompton Hospital.
Cutting Edge Research
Dr. Nijjer is committed to the better treatment of patients through the development and application of new medical technologies. His PhD and on-going research programme has involved the development of new techniques to measure blood flow in coronary arteries with blockages. His PhD was awarded by Imperial College London and was supported by the prestigious Medical Research Council (UK). During this time, Dr. Nijjer pioneered the use of iFR and iFR-pullback to better treat coronary blockages . iFR and iFR-Scout are now used in thousands of patients around the world as a result of Dr. Nijjer’s work, and has recently been called the ‘new gold standard’ by Editorialists in the New England Journal of Medicine.
Published in the best medical journals
The research from his PhD has been published in a number of major cardiology journals and he has personally presented his work at some of the leading cardiology conferences across the world, such as the American College of Cardiology and the European Society of Cardiology. Dr Nijjer has over 70 high-impact publications to his name, including the New England Journal of Medicine, The Lancet, Journal of the American College of Cardiology and the European Heart Journal. Among his awards and prizes, Dr. Nijjer was a finalist at the Royal Society of Medicine Gold Medal Competition 2015 and a finalist for BCIS Young Investigator 2015. That same year he was awarded the British Heart Foundation prize for best Research Abstract in Coronary Intervention, and CRT Young Leader prize.
The New England Journal of Medicine is amongst the highest ranked medical journals